Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder

This post was originally published on this site

Original post: March 31, 2022 11:03 am Newswise - Drug and Drug Abuse Northeastern University and Copernicus Therapeutics, Inc. Awarded $14.7 Million NIDA/NIH Grant to Develop a Gene Therapy Approach for Treating Opioid Use Disorder

Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University’s Bouve College of Health Sciences, is the Principal Investigator and Project Director for the grant.